ImageneBio (IMA) Return on Capital Employed (2021 - 2025)

ImageneBio has disclosed Return on Capital Employed across 5 years of filings, most recently posting 52.47% for Q3 2025.

• Return on Capital Employed for Q3 2025 came in at 52.47%, down 1219.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 52.47% (down 1219.0% YoY), and the FY2024 annual result was 67.94%, down 2304.0% from the prior year.
• Return on Capital Employed came in at 52.47% for Q3 2025 at ImageneBio, down from 37.05% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 15.0% in Q4 2021 to a low of 98.4% in Q4 2024.
• The 5-year median for Return on Capital Employed is 39.8% (2023), against an average of 40.99%.
• Across the five-year window, Return on Capital Employed sank 5860 bps in 2024 and jumped 1103 bps in 2025, its largest moves.
• ImageneBio's Return on Capital Employed stood at 15.0% in 2021, then slumped by 196 bps to 44.35% in 2022, then increased by 10 bps to 39.8% in 2023, then slumped by 147 bps to 98.4% in 2024, then surged by 47 bps to 52.47% in 2025.
• The last three Return on Capital Employed figures came in at 52.47% (Q3 2025), 37.05% (Q2 2025), and 80.46% (Q1 2025), per Business Quant data.